Latest News
Halfpenny Technologies, a provider of clinical data integration solutions specialising in laboratory, pathology and physician electronic medical record system interoperability, has secured USD2.6m in venture capital funding co-led by Pennsylvania-based Osage Venture Partners and New York-based Milestone Venture Partners.
Lore Associates, a Philadelphia-based angel group, also participated in the round.
“We are extremely pleased to have the support of investors who affirm our vision of providing innovative clinical data integration solutions for hospitals and laboratories,” says Jerry Baker, chief executive of Halfpenny Technologies. “With this financing, the company is well-positioned to deliver its Lab Hub platform to meet the increasing
Mountain Acquisition and Mountain Merger Sub, both affiliates of Vestar Capital Partners V, have completed the cash tender offer for all of the outstanding shares of common stock of HealthGrades at a purchase price of USD8.20 per share in cash, without interest and less any applicable withholding taxes.
The tender offer expired at 9am New York City time on 7 October 2010.
“Now more than ever, consumers are looking for trusted sources to help make informed healthcare choices,” says Roger Holstein, managing director of Vestar and co-head of its healthcare sector. “With more than 200 million annual visitors to the
Capital raised by US private equity funds has fallen despite a rise in the number of funds raising capital.
During the first three quarters of 2010, 279 funds raised USD68.8bn, a ten per cent drop in capital raised from the same period last year when 266 funds secured USD76.7bn, according to Dow Jones LP Source, an industry database that tracks private equity fundraising.
"Although limited partners are willing to support strong performers and certain niche investment strategies, they are often committing the same size or smaller amounts than they did during the prior fund-raising cycle," says Laura Kreutzer, assistant managing
Climate Change Capital Private Equity, a EUR200m fund which invests in later stage European cleantech companies, has appointed a panel of energy and cleantech professionals to advise its investment team.
The advisory panel includes: Peter Jones, former Biffa director; Lord Oxburgh, former non-executive chairman of Royal Dutch Shell; Dr Gayle Jackson, president and chief executive officer of Energy Global; Thomas Seibold, partner and member of the board of the Base Group; and Dr Anthony White, adviser to Climate Change Capital and founding member of the UK Government’s Energy Advisory Panel.
The panel will act as a sounding board for CPE’s
The National Pensions Reserve Fund will commit EUR30m to two venture capital funds in support of Innovation Fund Ireland.
Innovation Fund Ireland is a government initiative to attract international venture capital fund managers to Ireland.
DFJ Esprit Fund III (EUR20m) and DFJ Fund X (EUR10m) are the recipients of the investment.
DFJ Esprit is a pan-European venture capital firm that has backed companies such as Lovefilm, Buy.at and Imagine in Ireland.DFJ is an investor in emerging technologies and has backed companies such as Skype and Tesla Motors.
DFJ Esprit has also appointed Brian Caulfield as a partner of the firm
Mid Europa Partners has completed the acquisition of 100 per cent of Med-Sport, the Polish healthcare services provider.
Med-Sport offers CT and MRI imaging diagnostic services to public and private customers, through five facilities located in Southern Poland.
Pawel Padusinski, associate director of Mid Europa who led the transaction, says: “We are very pleased to have completed the acquisition of Med-Sport, which represents a further step in Mid Europa’s ongoing consolidation of the Polish healthcare market initiated with the acquisitions of Lux Med and Medycyna Rodzinna in 2007, CM LIM and Promedis in 2008 and TP Med and Tabita
AlertMe, an online energy management company, has closed its second round funding raising a total of GBP15m.
Existing investors Good Energies, Index Ventures, SET Venture Partners and VantagePoint Venture Partners have each followed their first round investment and are joined by a new investor and commercial partner British Gas (parent company Centrica).
As part of this investment British Gas has signed a commercial agreement worth over GBP20m based upon technology delivery to deploy AlertMe products and services to its customers in the UK. Following this transaction, British Gas will hold a seat on the AlertMe board.
The fundraising will allow
Private equity firm Warburg Pincus has agreed to invest USD150m in National Penn Bancshares through a direct purchase of newly issued common stock at USD6.05 per share, approximating the average closing price of the stock over the last 30 days.
The initial investment of USD63.3m will be funded within ten days, with the remainder of the investment to be made after receipt of regulatory approvals, which are anticipated in the fourth quarter of 2010.
"We are excited to have Warburg Pincus join us as a significant shareholder, with its longstanding record of successful investing in the financial services industry and
Genstar Capital, a middle market private equity firm that focuses on investments in the life sciences, healthcare, financial services, software and industrial technology industries, has appointed David J. Golde and Brett J. Shobe as senior associates.
They will help the firm identify, evaluate and execute acquisition and investment opportunities.
"We continue to strengthen our existing team of talented professionals and are pleased that David and Brett have joined Genstar. As we continue to build on our success as a leading middle market private equity investment firm, they will fit well with the management-centric and entrepreneurial culture of the firm and
Mid Europa Partners has completed the sale of Calucem’s operating assets to Argus Capital Partners.
Calucem is a supplier of calcium aluminate cement. With production facilities based in Croatia and sales offices in Germany, the US and Singapore, the company supplies cement to the global refractory and building chemistry industries.
Robert Knorr, partner of Mid Europa, says: "We are proud of the management’s response to the global economic crisis, which had an unprecedented impact across the industry. The company has experienced a rapid recovery in 2010 and is well-positioned for continued growth."
Laszlo Grubits, investment director of Argus,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
